127 results
6-K
CANF
Can-Fite Biopharma Ltd
25 Apr 24
Current report (foreign)
7:03am
-Fite BioPharma Ltd. issued a press release entitled “Long-term Complete Response to Can-Fite’s Namodenoson in Patient with Advanced Liver Cancer
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
25 Apr 24
Current report (foreign)
7:03am
Exhibit 99.1
Long-term Complete Response to Can-Fite’s Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific … and Therapeutic Medicine Journal, titled “Long-term complete response to namodenoson in liver cancer with Child-Pugh B cirrhosis: A case report
POS AM
CANF
Can-Fite Biopharma Ltd
5 Apr 24
Prospectus update (post-effective amendment)
4:15pm
other comprehensive income
Accumulated deficit
Total shareholder’s equity
Total capitalization (long-term liabilities and equity)
SELLING
6-K
EX-99.1
rf5kzidqs
28 Mar 24
Can-Fite Reports 2023 Financial Results and Clinical Update
7:05am
F-3/A
32nft3q0ow 8ymz3t
28 Dec 23
Shelf registration (foreign) (amended)
4:16pm
F-3
jovs5sac
12 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99.1
sj72 wuoj
30 Nov 23
Can-Fite Reports Third Quarter 2023 Financial Results and Clinical Update
7:05am
POS AM
q9g7c
1 Sep 23
Prospectus update (post-effective amendment)
4:16pm
F-3
jtqdss5km18 2fdg5m
1 Sep 23
Shelf registration (foreign)
4:15pm
6-K
EX-99.3
e2a6ydxx6x0q50p5je
31 Aug 23
Report of Foreign Private Issuer
7:12am
6-K
EX-99.2
3h247l
31 Aug 23
Report of Foreign Private Issuer
7:12am
6-K
EX-99.1
d0s81q8vcyyrptan5 3c
1 Jun 23
Can-Fite Reports First Quarter 2023 Financial Results & Provides Clinical Update
7:07am
POS AM
fu4r6b1zgjxq gofce
21 Apr 23
Prospectus update (post-effective amendment)
4:16pm
POS AM
apnb q2n3udf35gdd98
31 Mar 23
Prospectus update (post-effective amendment)
4:30pm
6-K
EX-99.1
fs7p4wmkg
30 Mar 23
Can-Fite Reports 2022 Financial Results & Provides Clinical Update
7:56am
6-K
EX-99.1
qx3e9vzskv8a
25 Nov 22
Can-Fite Reports Third Quarter 2022 Financial Results & Provides Clinical Update
7:12am
6-K
EX-99.1
xovaz4 2g
12 Sep 22
Report of Foreign Private Issuer
7:02am